Concepedia

Youngrock Jung

YJ

Statistics

Publications

4

Citations

251

H-Index

4

Active since

2018

Affiliations

Houston Methodist(Current)

Texas Children's Hospital

Baylor College of Medicine

Methodist Hospital

Imperial College London

Youngrock Jung is an author at Houston Methodist specializing in oncology, immunotherapy, and immunology.

Publications per year

2018–2021

4

Publications

4

Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors

Caroline E. Porter, Amanda Rosewell Shaw, Youngrock Jung et al. · Molecular Therapy · 2020 · 143 citations · Full text

Medicine, Immunology, Oncology +17

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors

Amanda Rosewell Shaw, Caroline E. Porter, Tiffany Yip et al. · Communications Biology · 2021 · 42 citations · Full text

Pharmacy, Immunology, Oncology +17

The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer

Jane Antony, Elisa Zanini, Zoe Kelly et al. · EMBO Reports · 2018 · 35 citations · Full text

Medicine, Cancer Biology, Oncology +12

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer

John Wahba, Marina Natoli, Lynsey M. Whilding et al. · Cancer Immunology Immunotherapy · 2018 · 31 citations · Full text

Life Sciences, Immunology, Oncology +17

1–4 of 4